Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3360)
All Articles published online
|
May 14, 2008 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang XD, Fan Y, Zhang H, Wang P, Yuan JP, Li MJ, Zhan XY. Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol 2008; 14(18): 2888-2893 [PMID: 18473416 DOI: 10.3748/wjg.14.2888] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i18/2888.htm |
| Number | Citing Articles |
| 1 |
Scott McNear, Stephen A. Harrison. Review: Current status of therapy in nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2009; 2(1): 29 doi: 10.1177/1756283X08100327
|
| 2 |
Giovanni Tarantino. Gut Microbiome, Obesity-Related Comorbidities, and Low-Grade Chronic Inflammation. The Journal of Clinical Endocrinology & Metabolism 2014; 99(7): 2343 doi: 10.1210/jc.2014-2074
|
| 3 |
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology. 2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
|
| 4 |
Shira Zelber-Sagi, Vlad Ratziu, Izabel Zvibel, Ilana Goldiner, Laurie Blendis, Gilles Morali, Zamir Halpern, Ran Oren. The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury. European Journal of Gastroenterology & Hepatology 2012; 24(3): 262 doi: 10.1097/MEG.0b013e32834f15dd
|
| 5 |
Chenyang Zhang, Bin Zhang, Xuelian Zhang, Min Wang, Xiaobo Sun, Guibo Sun. Panax notoginsengSaponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation. Journal of the American Heart Association 2022; 11(4) doi: 10.1161/JAHA.121.023540
|
| 6 |
Sandra Milić, Davorka Lulić, Davor Štimac. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations. World Journal of Gastroenterology 2014; 20(28): 9330-9337 doi: 10.3748/wjg.v20.i28.9330
|
| 7 |
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Medical Journal 2017; 135(3): 277 doi: 10.1590/1516-3180.2016.0306311216
|
| 8 |
S. Petta, C. Muratore, A. Craxì. Non-alcoholic fatty liver disease pathogenesis: The present and the future. Digestive and Liver Disease 2009; 41(9): 615 doi: 10.1016/j.dld.2009.01.004
|
| 9 |
Lucia De la Cruz-Color, Jose Alfredo Dominguez-Rosales, Montserrat Maldonado-González, Bertha Ruíz-Madrigal, Martha P. Sánchez Muñoz, Vianney Alejandrina Zaragoza-Guerra, Victor H. Espinoza-Padilla, Elizabeth del C. Ruelas-Cinco, Sandra M. Ramírez-Meza, José R. Torres Baranda, María del R. González-Gutiérrez, Zamira Helena Hernandez Nazara. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in Humans. International Journal of Molecular Sciences 2024; 25(12): 6420 doi: 10.3390/ijms25126420
|
| 10 |
Yoichi Asaoka, Shuji Terai, Isao Sakaida, Hiroshi Nishina. The expanding role of fish models in understanding non-alcoholic fatty liver disease. Disease Models & Mechanisms 2013; doi: 10.1242/dmm.011981
|
| 11 |
I. Rodriguez-Ramiro, D. Vauzour, A. M. Minihane. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proceedings of the Nutrition Society 2016; 75(1): 47 doi: 10.1017/S0029665115004218
|
| 12 |
Yan Chen, Wenkan Liu, Jun Ma, Yaorong Wang, Hai Huang. Comprehensive physiological and transcriptomic analysis revealing the responses of hybrid grouper (Epinephelus fuscoguttatus♀ × E. lanceolatus♂) to the replacement of fish meal with soy protein concentrate. Fish Physiology and Biochemistry 2020; 46(6): 2037 doi: 10.1007/s10695-020-00851-3
|
| 13 |
Pierre-Antoine Soret, Julie Magusto, Chantal Housset, Jérémie Gautheron. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. Journal of Clinical Medicine 2020; 10(1): 36 doi: 10.3390/jcm10010036
|
| 14 |
Giovanni Tarantino, Vincenzo Citro, Mauro Cataldi. Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?. Viruses 2021; 13(7): 1285 doi: 10.3390/v13071285
|
| 15 |
Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu-Sang Park. Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease. Gut and Liver 2022; 16(2): 171 doi: 10.5009/gnl210106
|
| 16 |
Maria Petrescu, Sonia Irina Vlaicu, Lorena Ciumărnean, Mircea Vasile Milaciu, Codruța Mărginean, Mira Florea, Ștefan Cristian Vesa, Monica Popa. Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. Medicina 2022; 58(5): 641 doi: 10.3390/medicina58050641
|
| 17 |
J. K. Dowman, J.W. Tomlinson, P.N. Newsome. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010; 103(2): 71 doi: 10.1093/qjmed/hcp158
|
| 18 |
Ancha Baranova, Aybike Birerdinc, Zobair M. Younossi. Adipose Tissue and Adipokines in Health and Disease. 2014; : 249 doi: 10.1007/978-1-62703-770-9_17
|
| 19 |
María Eugenia Inzaugarat, Elena De Matteo, Placida Baz, Diego Lucero, Cecilia Claudia García, Esteban Gonzalez Ballerga, Jorge Daruich, Juan Antonio Sorda, Miriam Ruth Wald, Alejandra Claudia Cherñavsky, Vida A. Dennis. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. PLOS ONE 2017; 12(3): e0172900 doi: 10.1371/journal.pone.0172900
|
| 20 |
Israt Ara Hossain, Salima Akter, Mohammad Khalilur Rahman, Liaquat Ali, Harpal Singh Randeva. Gender Specific Association of Serum Leptin and Insulinemic Indices with Nonalcoholic Fatty Liver Disease in Prediabetic Subjects. PLOS ONE 2015; 10(11): e0142165 doi: 10.1371/journal.pone.0142165
|
| 21 |
Julian Schwärzler, Felix Grabherr, Christoph Grander, Timon E. Adolph, Herbert Tilg. The pathophysiology of MASLD: an immunometabolic perspective. Expert Review of Clinical Immunology 2024; 20(4): 375 doi: 10.1080/1744666X.2023.2294046
|
| 22 |
Hyun-Seuk Moon, Maria Dalamaga, Sang-Yong Kim, Stergios A. Polyzos, Ole-Petter Hamnvik, Faidon Magkos, Jason Paruthi, Christos S. Mantzoros. Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals. Endocrine Reviews 2013; 34(3): 377 doi: 10.1210/er.2012-1053
|
| 23 |
Yuexia Zhang, Shanshan Ge, Zhenhua Yang, Zhongping Li, Xiaojuan Gong, Quanxi Zhang, Wenjuan Dong, Chuan Dong. Disturbance of di-(2-ethylhexyl) phthalate in hepatic lipid metabolism in rats fed with high fat diet. Food and Chemical Toxicology 2020; 146: 111848 doi: 10.1016/j.fct.2020.111848
|
| 24 |
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
|
| 25 |
Adel Hammoutene, Pierre-Emmanuel Rautou. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. Journal of Hepatology 2019; 70(6): 1278 doi: 10.1016/j.jhep.2019.02.012
|
| 26 |
Roya Navekar, Maryam Rafraf, Aida Ghaffari, Mohammad Asghari-Jafarabadi, Manouchehr Khoshbaten. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. Journal of the American College of Nutrition 2017; 36(4): 261 doi: 10.1080/07315724.2016.1267597
|
| 27 |
Yu Wang, Mingyan Zhou, Karen S. L. Lam, Aimin Xu. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Arquivos Brasileiros de Endocrinologia & Metabologia 2009; 53(2): 201 doi: 10.1590/S0004-27302009000200012
|
| 28 |
Shankar Baskar, Simone Jhaveri, Naim Alkhouri. Cardiovascular risk in pediatric nonalcoholic fatty liver disease: recent advances. Clinical Lipidology 2015; 10(4): 351 doi: 10.2217/clp.15.26
|
| 29 |
Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 2017; 72: 94 doi: 10.1016/j.metabol.2017.04.011
|
| 30 |
Hessah Al‑Muzafar, Kamal Amin. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl‑CoA desaturase‑1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6563
|
| 31 |
T.O. Elufioye, O.I. Alatise, F.A. Fakoya, J.M. Agbedahunsi, P.J. Houghton. Toxicity studies of Tithonia diversifolia A. Gray (Asteraceae) in rats. Journal of Ethnopharmacology 2009; 122(2): 410 doi: 10.1016/j.jep.2008.12.007
|
| 32 |
Christina-Maria Flessa, Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, Harpal S. Randeva. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. International Journal of Molecular Sciences 2022; 23(24): 15791 doi: 10.3390/ijms232415791
|
| 33 |
Laureane Nunes Masi, Amanda Roque Martins, Amanda Rabello Crisma, Cátia Lira do Amaral, Mariana Rodrigues Davanso, Tamires Duarte Afonso Serdan, Roberta Dourado Cavalcante da Cunha de Sá, Maysa Mariana Cruz, Maria Isabel Cardoso Alonso-Vale, Rosângela Pavan Torres, Jorge Mancini-Filho, Joice Naiara Bertaglia Pereira, Marta Maria da Silva Righetti, Edson Aparecido Liberti, Sandro Massao Hirabara, Rui Curi. Combination of a high-fat diet with sweetened condensed milk exacerbates inflammation and insulin resistance induced by each separately in mice. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04308-1
|
| 34 |
Ju Ri Ham, Hae-In Lee, Ra-Yeong Choi, Mi-Ok Sim, Kwon-Il Seo, Mi-Kyung Lee. Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice. Food & Function 2016; 7(2): 689 doi: 10.1039/C5FO01329A
|
| 35 |
María Gabriela Delgado, Jordi Gracia-Sancho, Giusi Marrone, Aina Rodríguez-Vilarrupla, Ramon Deulofeu, Juan G. Abraldes, Jaume Bosch, Juan Carlos García-Pagán. Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 305(7): G496 doi: 10.1152/ajpgi.00336.2012
|
| 36 |
Hironori Mizutani, Satoshi Fukushima, Shinichi Masuguchi, Junji Yamashita, Azusa Miyashita, Satoshi Nakahara, Jun Aoi, Yuji Inoue, Masatoshi Jinnin, Hironobu Ihn. Serum levels of leptin receptor in patients with malignant melanoma as a new tumor marker. Experimental Dermatology 2013; 22(11): 748 doi: 10.1111/exd.12238
|
| 37 |
Mariana V. Machado, João Coutinho, Fátima Carepa, Adília Costa, Helena Proença, Helena Cortez-Pinto. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2012; 24(10): 1166 doi: 10.1097/MEG.0b013e32835609b0
|
| 38 |
Mohammad Ariya, Farbod Koohpayeh, Alireza Ghaemi, Saeed Osati, Sayed Hossain Davoodi, Jalaledin Mirzay Razzaz, Gholamali Javedan, Elham Ehrampoush, Reza Homayounfar, Gianfranco D. Alpini. Assessment of the association between body composition and risk of non-alcoholic fatty liver. PLOS ONE 2021; 16(4): e0249223 doi: 10.1371/journal.pone.0249223
|
| 39 |
Stergios A. Polyzos, Konstantinos N. Aronis, Jannis Kountouras, Dimitrios D. Raptis, Maria F. Vasiloglou, Christos S. Mantzoros. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Diabetologia 2016; 59(1): 30 doi: 10.1007/s00125-015-3769-3
|
| 40 |
Li Zhang, Haiyan Song, Yingli Ge, Guang Ji, Zemin Yao, Julie A. Chowen. Temporal Relationship between Diet-Induced Steatosis and Onset of Insulin/Leptin Resistance in Male Wistar Rats. PLOS ONE 2015; 10(2): e0117008 doi: 10.1371/journal.pone.0117008
|
| 41 |
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. American Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
|
| 42 |
Richard Parker. The role of adipose tissue in fatty liver diseases. Liver Research 2018; 2(1): 35 doi: 10.1016/j.livres.2018.02.002
|
| 43 |
Shadi S. Yarandi, Gautam Hebbar, Cary G. Sauer, Conrad R. Cole, Thomas R. Ziegler. Diverse roles of leptin in the gastrointestinal tract: Modulation of motility, absorption, growth, and inflammation. Nutrition 2011; 27(3): 269 doi: 10.1016/j.nut.2010.07.004
|
| 44 |
Hao Zheng, Shilin Li, Liang Ma, Ling Cheng, Chongyang Deng, Zhizhi Chen, Caifeng Xie, Mingli Xiang, Wei Jiang, Lijuan Chen. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance. European Journal of Pharmacology 2011; 659(2-3): 244 doi: 10.1016/j.ejphar.2011.03.033
|
| 45 |
Margalida Monserrat-Mesquida, Cristina Bouzas, Catalina M. Mascaró, Silvia Tejada, Antoni Sureda. Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD). Fermentation 2023; 9(4): 395 doi: 10.3390/fermentation9040395
|
| 46 |
Huong Thi Nguyen, Mingkun Gu, Pia Werlinger, Joo-Hyung Cho, Jinhua Cheng, Joo-Won Suh. Lactobacillus sakei MJM60958 as a Potential Probiotic Alleviated Non-Alcoholic Fatty Liver Disease in Mice Fed a High-Fat Diet by Modulating Lipid Metabolism, Inflammation, and Gut Microbiota. International Journal of Molecular Sciences 2022; 23(21): 13436 doi: 10.3390/ijms232113436
|
| 47 |
Xiao-Min Xin, Mu-Xiao Zhong, Gong-Li Yang, Yao Peng, Ya-Li Zhang, Wei Zhu. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells. World Journal of Gastroenterology 2014; 20(42): 15727-15735 doi: 10.3748/wjg.v20.i42.15727
|
| 48 |
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Leptin in nonalcoholic fatty liver disease: A narrative review. Metabolism 2015; 64(1): 60 doi: 10.1016/j.metabol.2014.10.012
|
| 49 |
Jun Zhao, Matthew W. Lawless. Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer. Cytokine 2013; 64(3): 626 doi: 10.1016/j.cyto.2013.09.009
|
| 50 |
Mithun Sharma, Shasikala Mitnala, Ravi K. Vishnubhotla, Rathin Mukherjee, Duvvur N. Reddy, Padaki N. Rao. The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. Journal of Clinical and Experimental Hepatology 2015; 5(2): 147 doi: 10.1016/j.jceh.2015.02.002
|
| 51 |
Andrea Bell, Soheila Korourian, Huawei Zeng, Joshua Phelps, Reza Hakkak. A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model. Food & Function 2017; 8(3): 1293 doi: 10.1039/C6FO01772J
|
| 52 |
Farnaz Farsi, Majid Mohammadshahi, Pezhman Alavinejad, Afshin Rezazadeh, Mehdi Zarei, Kambiz Ahmadi Engali. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Journal of the American College of Nutrition 2016; 35(4): 346 doi: 10.1080/07315724.2015.1021057
|
| 53 |
Ramya Bhat S, Indumathi Shankaraiah. STUDY OF PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL. Journal of Evolution of Medical and Dental Sciences 2019; 8(23): 1830 doi: 10.14260/jemds/2019/402
|
| 54 |
Min‐Hsiung Pan, Ching‐Shu Lai, Mei‐Ling Tsai, Chi‐Tang Ho. Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. Molecular Nutrition & Food Research 2014; 58(1): 147 doi: 10.1002/mnfr.201300522
|
| 55 |
Sanjali Charles, Yutong Liu, Wandia Kimita, Juyeon Ko, Sakina H. Bharmal, Maxim S. Petrov. Effect of d-β-hydroxybutyrate-(R)-1,3 butanediol on plasma levels of asprosin and leptin: results from a randomised controlled trial. Food & Function 2023; 14(2): 759 doi: 10.1039/D2FO02405E
|
| 56 |
Masakazu Umezawa, Masayuki Nakamura, Ashraf A. El-Ghoneimy, Atsuto Onoda, Hazem M. Shaheen, Hiroshi Hori, Yusuke Shinkai, Yasser S. El-Sayed, Ali H. El-Far, Ken Takeda. Impact of diesel exhaust exposure on the liver of mice fed on omega-3 polyunsaturated fatty acids-deficient diet. Food and Chemical Toxicology 2018; 111: 284 doi: 10.1016/j.fct.2017.11.027
|
| 57 |
Vian Azzu, Michele Vacca, Samuel Virtue, Michael Allison, Antonio Vidal-Puig. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease. Gastroenterology 2020; 158(7): 1899 doi: 10.1053/j.gastro.2019.12.054
|
| 58 |
Kalliopi Pafili, Michael Roden. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Molecular Metabolism 2021; 50: 101122 doi: 10.1016/j.molmet.2020.101122
|
| 59 |
Wei-ning Jiang, Dan Li, Tao Jiang, Jiao Guo, Yan-fen Chen, Jie Wang, Yun Zhou, Chao-yan Yang, Chun-ping Tang. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Chinese Journal of Integrative Medicine 2018; 24(2): 125 doi: 10.1007/s11655-016-2252-4
|